Patient1 | Patient2 | Patient3 | Patient4 | Patient5 | Patient6 | |
---|---|---|---|---|---|---|
Demographics | ||||||
Sex (Male/Female) | M | F | F | F | M | F |
Age at diagosis of SS (years) | 18 | 26 | 35 | 53 | 42 | 61 |
Disease duration (months) | 12 | 2 | 4 | 3 | 72 | 3 |
Diagosis criteria for SS | ||||||
Dry eye | - | - | - | - | - | + |
Dry mouth | - | - | - | + | - | - |
Shirmer's test | - | NA | NA | NA | - | + |
Decreased salivary flow | - | - | - | - | + | + |
Parotid swelling | - | - | - | - | - | - |
Pathologic salivary gland biopsy ( focal lymphocytic sialad | + | + | + | + | + | + |
FS | 1 | 2 | 1 | 1 | 2 | 2 |
Anti-SSA | + | + | + | + | + | + |
Anti-SSB | + | - | - | - | + | - |
Anti-SSA/Ro-52 | - | + | - | + | + | + |
Clinical manifestation | ||||||
Upper promixal(MRC ≤ 3) | - | - | - | - | - | + |
Upper distal(MRC ≤ 3) | - | - | - | - | - | - |
Lower promixal(MRC ≤ 3) | - | - | + | + | - | + |
Lower distal(MRC ≤ 3) | - | - | - | - | - | + |
MMT | 230 | 184 | 240 | 206 | 235 | 140 |
DAS | 2 | 6 | 2 | 3 | 1 | 7 |
MYOCAT | 16 | 15 | 5 | 5 | 5 | 21 |
Atrophy | - | - | - | - | - | - |
Dyspnea | - | - | - | - | - | - |
Dysphagia | - | - | - | - | - | - |
Myalgia | + | - | - | + | - | + |
Thyroid dysfunction | + | - | - | + | - | + |
Lupus Anticoagulant | - | - | - | - | - | - |
Cutaneous | - | - | - | - | - | + |
Statin exposure | - | - | - | - | - | - |
Smoking | - | - | - | - | - | - |
Drinking | - | - | - | - | - | - |
Diabete | - | - | - | - | - | - |
Hypertension | - | - | - | - | + | - |
Renal | - | - | - | - | - | - |
B cell lymphoma | - | - | - | - | - | - |
Central nervous system | - | - | - | - | - | - |
Peripheral nervous system | - | - | - | - | - | - |
Arthritis | - | - | - | - | - | - |
Pulmonary | - | + | - | + | - | - |
Cardiac abnormality | + | - | - | + | + | - |
Vascular | - | - | - | - | - | - |
Haematological | - | - | - | - | - | - |
Raynaud's phenomena | - | - | - | - | - | - |
Examination | ||||||
ANCA | - | - | - | - | - | - |
ANA Titer | + | + | + | + | - | + |
ElevatedCK level (U/l) | 8419 | 7853 | 9516 | 321 | 7319 | 4000 |
Elevated LDH level (U/l) | 1621 | 410 | 377 | 454 | 1306 | 793 |
AST (U/l) | 130 | 148 | 267 | 25 | 136 | 121 |
ALT (U/l) | 127 | 144 | 172 | 25 | 368 | 218 |
Myoglobin(ng/ml) | 729.6 | 672.6 | 862.9 | > 1200 | - | 894 |
CK-MB(ng/ml) | 157 | 64.3 | 968 | 115.4 | - | - |
TnI(pg/ml) | 12 | 19 | - | - | 22 | - |
NI-PRO-BNP(pg/ml) | - | - | - | 290 | - | - |
ESR(mm/H) | - | - | - | 16 | 25 | - |
hsCRP (mg/L) | NA | 0.3 | 0.2 | NA | 5 | 8 |
Alb(g/L) | 44.2 | 33.7 | 33.7 | 44.7 | 32.5 | 39.7 |
Glb(g/L) | 24.7 | 34.2 | NA | 27.9 | 23 | 23.8 |
IgA(g/L) | 3.5 | 2.3 | NA | 1.69 | NA | 2.44 |
IgG(g/L) | 15 | 13 | NA | 13.4 | NA | 13.9 |
IgM(g/L) | 1.5 | 0.89 | NA | 2.22 | NA | 0.84 |
C3(g/L) | 1.1 | 0.69 | NA | 0.98 | NA | 0.93 |
C4(g/L) | 0.25 | 0.16 | NA | 0.18 | NA | 0.23 |
Pathological examination | ||||||
Labial glands biopsy ( focal lymphocytic sialadenitis with a | + | + | + | + | + | + |
Treatment outcome | ||||||
Immunomodulatory treatment | RTX | TAC,PNL | TAC,PNL | MP | TAC,PNL | TAC,PNL |
Follow-up(months) | 72 | 8 | 6 | 36 | 120 | 36 |
Dry eye | - | - | - | - | - | - |
Dry mouth | - | - | - | - | - | + |
No improvement | - | - | - | - | - | - |
improvement | + | - | + | + | + | + |
Marked improvement | - | + | - | - | - | - |
Clinical relapse | + | - | - | - | - | - |